Schedule - Emory Center for AIDS Research

PROBeX: Site Visits and Monitoring SOP (1296)

PROBeX SOP TB/Coinfection Studies PROBeX HIV Laboratory Participant Staff Testing Visit Site Protocol Drug Deviation Monitor Review ART Treatment Protection Subjects Report Africa Tuberculosis Patient Diagnosis XDR Storage Documents Document Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Schedule Actions International Activities Violation Debrief International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX international staff monitoring SOP.

PROBeX: Obtaining and Reporting Clinic and Lab Assessments SOP (1284)

PROBeX SOP TB/Coinfection Studies PROBeX Counseling HIV Laboratory Research Testing Safety Test Height Weight Drug Viral Lab Clinic Pregnancy ART Treatment Report Urine Assessment Load Africa Tuberculosis Patient Sputum CD4 Diagnosis Blood XDR Storage Plasma Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Schedule X-ray Draw Electrocardiogram International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Reporting lab assessments SOP for PROBeX.

PROBeX: Intensive PK Sampling CRF

PROBeX CRF TB/Coinfection Studies PROBeX Administration HIV Testing History Collection Height Weight Drug Specimen ART Treatment Dose Urine Africa Tuberculosis Transport Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Sampling Schedule PK Physical Exam Linezolid Levofloxacin Pyrazinamide Ethionamide Isoniazid Vomit Draw Hours Minutes International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Intensive PK sampling CRF for PROBeX study.

PROBeX: Protocol (1267)

PROBeX Consent Forms TB/Coinfection Studies PROBeX Consent HIV Screening Data Procedure Recruitment Testing Analysis Benefits Monitoring Protocol Risks Confidentiality Timeline Drug Informed Viral Clinic ART Antiretroviral Treatment Urine Load Africa Tuberculosis Mortality Hospitals Sputum CD4 Diagnosis Blood Storage Plasma Documentation Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Global FDA Inhibitor Transmissions Genome Sequencing Therapy Pharmacodynamics Schedule Pharmacogenetics PK Sub-study Phlebotomy Populations Vulnerable International 2020 Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Protocol for PROBeX study.

PrEP@Home: Retention Plan SOP (1097)

PREP at Home SOP PREP@Home Appointment Baseline Example Follow-up Laboratory PrEP Participant Reminder Retention Staff SOP System Site Behavioral Monitoring Script Plan Care Responsibilities Persistence Remote Telemedicine Multi-Site Status Kit Schedule Coordinator Role Message Domestic 2023 Prevention Behavioral Health Equity mHealth Clinical Standard RCT Clinical Qual + Quant

SOP for participant retention plans, including retention coordinator roles and responsibilities, baseline appointment scheduling scripts, follow-up care kit and appointment reminders, example message scripts, and change of status at the end of the study for the PrEP@Home Study.